Gulyani Meeta
Transaction: 07/28/2026
BUY
Change
+25,000
Price
$2.14
Filing
07/30/2026
Type
BUY
Seer, Inc.
SEER • Biotechnology
$1.95
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$107.57M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 27.8%Manageable debt level · 0.09Healthy liquidity · 12.84Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.95
Change0.00%
Shares Out55.16M
Market Cap$107.57M
Enterprise Value$-22.89M
52W Range1.55 - 2.41
Beta1.52
P/E-1.58
P/S7.64
P/B0.48
P/FCF-2.43
EV/Sales-1.62
Price$1.95
Change0.00%
Shares Out55.16M
Market Cap$107.57M
Enterprise Value$-22.89M
52W Range1.55 - 2.41
Beta1.52
P/E-1.58
P/S7.64
P/B0.48
P/FCF-2.43
EV/Sales-1.62
EV/EBITDA0.34
EV/FCF0.52
Earnings Yield-63.18%
FCF Yield-41.12%
Dividend Yield0.00%
Gross Margin11.80%
Oper. Margin-4.87%
Profit Margin-4.57%
Debt/Eq0.09
Current Ratio12.84
Quick Ratio12.35
Target$4.00
Target Upside105.13%
Target Median$4.00
Target Range4.00 - 4.00
Volume508.84K
Avg Volume904.52K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Positive revenue growth · 27.8%Manageable debt level · 0.09Healthy liquidity · 12.84Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
50/100
Neutral
Bullish
1
Hold
2
Bearish
1
Price Target
2026-08-13
Low
$4.00
Mean
$4.00
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
Gulyani Meeta
Transaction: 07/28/2026
BUY
Change
+16,500
Price
Not reported
Filing
07/30/2026
Type
BUY
LANGER ROBERT
Transaction: 07/28/2026
BUY
Change
+25,000
Price
$2.14
Filing
07/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Gulyani Meeta | BUY | +25,000 | $2.14 | 07/28/2026 | 07/30/2026 |
| Gulyani Meeta | BUY | +16,500 | Not reported | 07/28/2026 | 07/30/2026 |
| LANGER ROBERT | BUY | +25,000 | $2.14 | 07/28/2026 | 07/30/2026 |
| LANGER ROBERT | BUY | +16,500 | Not reported | 07/28/2026 | 07/30/2026 |
| MCGUIRE TERRANCE | BUY | +25,000 | $2.14 | 07/28/2026 | 07/30/2026 |
| MCGUIRE TERRANCE | BUY | +16,500 | Not reported | 07/28/2026 | 07/30/2026 |
| Nishar Dipchand | BUY | +25,000 | $2.14 | 07/28/2026 | 07/30/2026 |
| Nishar Dipchand | BUY | +16,500 | Not reported | 07/28/2026 | 07/30/2026 |
| Ro Isaac | BUY | +18,750 | $2.14 | 07/28/2026 | 07/30/2026 |
| Ro Isaac | BUY | +12,375 | Not reported | 07/28/2026 | 07/30/2026 |
| Roelofs Nicolas H PHD | BUY | +25,000 | $2.14 | 07/28/2026 | 07/30/2026 |
| Roelofs Nicolas H PHD | BUY | +16,500 | Not reported | 07/28/2026 | 07/30/2026 |
| Nishar Dipchand | SELL | -10,660 | $2.18 | 07/08/2026 | 07/10/2026 |
| Horn David R. | SELL | -7,303 | $1.69 | 05/20/2026 | 05/21/2026 |
| Bazarko Anthony R. | BUY | +75,000 | Not reported | 05/08/2026 | 05/11/2026 |
| Bazarko Anthony R. | BUY | +225,000 | $1.87 | 05/08/2026 | 05/11/2026 |
| Bazarko Anthony R. | OTHER | 0 | Not reported | 05/04/2026 | 05/11/2026 |
| Farokhzad Omid | SELL | -24,385 | $1.99 | 02/18/2026 | 02/19/2026 |
| Horn David R. | SELL | -7,743 | $1.99 | 02/18/2026 | 02/19/2026 |
| Farokhzad Omid | BUY | +512,000 | $1.79 | 02/03/2026 | 02/05/2026 |